Association of Maternal Diabetes With Autism in Offspring
JAMA 2015;313(14):1425-34 http://jama.jamanetwork.com/article.aspx?articleid=2247143
Leggi
Risk and Recurrence of Serious Adverse Outcomes in the First and Second Pregnancies of Women With Preexisting Diabetes
Diabetes Care.2015;38(4):610-9 http://care.diabetesjournals.org/content/38/4/610.long
Leggi
Pioglitazone: are rumours of its death exaggerated?
E. A. M. Gale Diabetic Medicine 2015; 32(4):431-7 http://onlinelibrary.wiley.com/doi/10.1111/dme.12708/abstract?campaign=woletoc
Leggi
Pioglitazone: reports of its death are greatly exaggerated – it is alive and ready to resume saving lives
R. E. J. Ryder Diabetic Medicine 2015;32(4):e9–e15 http://onlinelibrary.wiley.com/doi/10.1111/dme.12736/abstract?campaign=woletoc
Leggi
Comparison of maternal morbidity and medical costs during pregnancy and delivery between patients with gestational diabetes and patients with pre-existing diabetes
K. H. Son, N.-K. Lim, J.-W. Lee et al. Diabetic Medicine 2015;32(4): 477-86 http://onlinelibrary.wiley.com/doi/10.1111/dme.12656/abstract?campaign=woletoc
Leggi
Fall in population-based mortality from coronary heart disease negated in people with diabetes mellitus: data from England
T. C. Ecclestone, D. G. R. YeatesandM. J. Goldacre Diabetic Medicine March 28, 2015 http://onlinelibrary.wiley.com/doi/10.1111/dme.12770/abstract
Leggi
The Influence of Diabetes, Glycemic Control, and Diabetes-Related Comorbidities on Pulmonary Tuberculosis
Chiang CY, Bai KJ, Lin HH et al. PLoS One 2015;10(3):e0121698 http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0121698
Leggi
Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes
Camelo Castillo W, Boggess K, Stürmer T et al. JAMA Pediatr Mar 30, 2015 http://archpedi.jamanetwork.com/article.aspx?articleid=2211139
Leggi
Glyburide for Gestational Diabetes: Time for a Pause for Thought
Holt RI JAMA Pediatr Mar 30, 2015 http://archpedi.jamanetwork.com/article.aspx?articleid=2211136
Leggi
Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoter
R. E. J. Ryder Diabetic Medicine2015;32(4):438-9 http://onlinelibrary.wiley.com/doi/10.1111/dme.12703/full
Leggi